BK Kishore
Sandy, UT (USA)
Role(s):
C-Level Executive (CEO, CFO, etc.)
ePurinens, Inc
Find More Startups
Startup
Location:
Salt Lake City
Industry:
Pharmaceuticals
Year Founded:
2020
Number Employees:
1-10 people
Business Stage:
Growth (not profitable)
Entity Type:
"C" Corporation
Description:
ePurines is a therapeutic drug development startup, a spin out from the University of Utah Health and the associated Veterans Affairs Medical Center in Salt Lake City, Utah, USA. Based on patented technologies, ePurines is focused to develop novel purinergic signaling-based orally effective small molecule drugs to address the global problem of overweight and obesity and non-communicable diseases (NCDs) affecting the kidney, liver, heart, and lung. Obesity is a global problem, with numerically large number of subjects living in emerging economies and developing countries, where they bear more health burdens than those in the developed world due to lack of mature healthcare systems. Currently popular anti-obesity drugs in the market are expensive and not suitable for use or penetration into the emerging economies and developing countries. Obviously, there is a huge unmet need for orally effective small molecule anti-obesity drugs that will modestly priced for penetration into the global markets. ePurines has a solution for that by targeting P2Y2 receptor. Targeting P2Y2 is also beneficial in many unrelated NCDs affecting different organs.